Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 15;11:7739–7749. doi: 10.2147/CMAR.S207801

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-485 reversed the carcinogenesis of NNT-AS1 on CCA cells.

Notes: (A–D) Functional assays identified the phenomenon of NNT-AS1 and BCL9 regulated each other to compete for the binding of miR-485 by wound healing assays, transwell invasion, migration assay and CCK8 in CCLP1 and QBC-939. (E) The expression levels of BCL9 in CCLP1 and QBC-939 cotransfected si-NNT-AS1 with miR-485 inhibitor was analyzed by Western blot. The error bars in all graphs represented SD.

Abbreviations: NC, negative control; NNT-AS1, nicotinamide nucleotide transhydrogenase antisense RNA 1.